Allison W. Kurian, M.D., M.Sc.
Academic Appointments
- Assistant Professor - Med Center Line, Medicine - Oncology
- Member, Stanford Cancer Institute
- Assistant Professor - Med Center Line, Health Research & Policy
Key Documents
Contact Information
-
Clinical Offices
Stanford Women�s Cancer Center 900 Blake Wilbur Stanford, CA 94305 Tel Work (650) 498-6004 Fax (650) 490-7237
- Academic Offices
Alternate Contact Oncology Clinic Tel Work 650-498-6000Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Breast Cancer
- Cancer Genetics
- Medical Oncology
- Breast Cancer Risk
Administrative Appointments
- Director, Cancer Education Seminar, Stanford Division of Oncology (2013 - present)
- Panel on Clinical Guidelines Development for Breast Cancer Risk Reduction, National Comprehensive Cancer Network (2013 - present)
- Advisory Committee, California HealthCare Foundation (2012 - present)
- Scientific Program Committee, Cancer Prevention and Epidemiology, American Society of Clinical Oncology (2011 - 2014)
- Scientific Program Committee, Quality Care Symposium, American Society of Clinical Oncology (2012 - 2015)
- Scientific Program Committee, Genetic and Molecular Epidemiology, American Association for Cancer Research (2011 - 2012)
Honors and Awards
- Top 12 publications funded by the Epidemiology and Genomics Research Program, National Cancer Institute (2012)
- New Clinical Investigator Award, Stanford Cancer Institute (2011)
- Translational Research Award, California Breast Cancer Research Program (2010)
- Jan Weimer Faculty Investigator Award for Breast Cancer Research, Stanford University (2008)
- Physician Faculty Scholars Award, Robert Wood Johnson Foundation (2008)
- Cornelius L. Hopper Research Abstract Award, California Breast Cancer Research Program (2007)
Professional Education
| Internship: | Massachusetts General Hospital MA (2000) |
| Residency: | Massachusetts General Hospital MA (2002) |
| Medical Education: | Harvard Medical School MA (1999) |
| M.Sc.: | Stanford University, Epidemiology (2006) |
| Board Certification: | Medical Oncology, American Board of Internal Medicine (2005) |
| Fellowship: | Stanford University School of Medicine CA (2005) |
Graduate & Fellowship Program Affiliations
Community and International Work
- FORCE: Facing Our Risk of Cancer Empowered, International&suffix=physician
- American Cancer Society, Santa Clara County&suffix=physician
- Breast Cancer Connections, Palo Alto, CA&suffix=physician
Scientific Focus
Current Research Interests
My research focuses on the genetics, epidemiology, prevention, and outcomes of women's cancers. This work is highly collaborative within the Stanford Divisions of Oncology and Epidemiology, with the Stanford Department of Radiology and Center for Biomedical Informatics Research, and with the Cancer Prevention Institute of California.
Ongoing projects include studies of the clinical epidemiology and outcomes of BRCA1/2 mutation-associated cancers, of breast cancer outcomes across diverse populations and treatment settings (the Oncoshare project), and of computer-based simulation modeling to evaluate new approaches to cancer screening and prevention.
Clinical Trials
- Not Recruiting Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
- Not Recruiting Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
- Recruiting A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women
- Recruiting A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
- Not Recruiting A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
Publications
- Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Breast Cancer Res Treat. 2013; (1): 247-60
- Oncoshare: lessons learned from building an integrated multi-institutional database for comparative effectiveness research. AMIA Annu Symp Proc. 2012: 970-8
- Online tool to guide decisions for BRCA1/2 mutation carriers. J Clin Oncol. 2012; (5): 497-506
- Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry. J Clin Oncol. 2011; (34): 4505-9
- Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res. 2010; (6): R99
- Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Clin Oncol. 2010; (2): 222-31
Help
Trial Administration